Efficacy of Dimethyl Fumarate in Young Adults with Relapsing-Remitting Multiple Sclerosis: Analysis of the DEFINE, CONFIRM, and ENDORSE Studies

被引：0
作者：
Lilyana Amezcua
Yang Mao-Draayer
Wendy S. Vargas
Rebecca Farber
Sara Schaefer
Filipe Branco
Sarah M. England
Nicholas Belviso
James B. Lewin
Jason P. Mendoza
Sai L. Shankar
机构：
[1] University of Southern California,Multiple Sclerosis Comprehensive Care Center
[2] University of Southern California,Department of Neurology, Keck School of Medicine
[3] University of Michigan Medical School,Autoimmunity Center of Excellence, Department of Neurology
[4] University of Michigan Medical School,Graduate Program in Immunology, Program in Biomedical Sciences
[5] Columbia University Irving Medical Center,Columbia Multiple Sclerosis Center, Department of Neurology
[6] UC-Health Neurology Clinic,Multiple Sclerosis Comprehensive Care Center
[7] Biogen,undefined
来源：
Neurology and Therapy | 2023年 / 12卷
关键词：
Dimethyl fumarate; DMT; Efficacy; Multiple sclerosis; Safety; Young adults;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：883 / 897
页数：14
相关论文
共 90 条
[1]  
Conradsson D(2018)Changes in disability in people with multiple sclerosis: a 10-year prospective study J Neurol 265 119-126
[2]  
Ytterberg C(2018)Multiple sclerosis Nat Rev Dis Prim 4 43-1136
[3]  
von Koch L(2017)New insights into the burden and costs of multiple sclerosis in Europe Mult Scler 23 1123-1758
[4]  
Johansson S(2016)The relationship of age with the clinical phenotype in multiple sclerosis Mult Scler 22 1750-959
[5]  
Filippi M(2006)Is late-onset multiple sclerosis associated with a worse outcome? Neurology 67 954-1928
[6]  
Bar-Or A(2021)Descriptive analysis of real-world data on fingolimod long-term treatment of young adult RRMS patients Front Neurol 12 637107-e2773
[7]  
Piehl F(2002)Course and prognosis in early-onset MS: comparison with adult-onset forms Neurology 59 1922-120
[8]  
Kobelt G(2019)Long-term disability progression of pediatric-onset multiple sclerosis Neurology 92 e2764-e110
[9]  
Thompson A(2018)ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis Mult Scler 24 96-807
[10]  
Berg J(2018)Early versus later treatment start in multiple sclerosis: a register-based cohort study Eur J Neurol 25 1262-16
123456789